Europe Clinical Nutrition Market Size (2024 - 2029)

The Europe Clinical Nutrition Market is projected to experience significant growth over the forecast period, driven by factors such as the increasing prevalence of metabolic disorders and heightened healthcare spending. The market's expansion is further supported by government initiatives aimed at raising awareness and providing guidelines on clinical nutrition. The COVID-19 pandemic underscored the importance of clinical nutrition in managing infection-related malnutrition, leading to a surge in product adoption, which has continued as restrictions have eased. Additionally, strategic activities by key market players, including product launches and collaborations, are expected to enhance product availability and contribute to market growth. However, misconceptions about clinical nutrition may pose challenges to the market's expansion.

Market Size of Europe Clinical Nutrition Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Europe Clinical Nutrition Market Summary
Study Period 2019-2029
Base Year For Estimation 2023
Market Size (2024) USD 21.02 Billion
Market Size (2029) USD 31.39 Billion
CAGR (2024 - 2029) 8.35 %
Market Concentration Medium

Major Players

Europe Clinical Nutrition Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Europe Clinical Nutrition Market Analysis

The Europe Clinical Nutrition Market size is estimated at USD 21.02 billion in 2024, and is expected to reach USD 31.39 billion by 2029, growing at a CAGR of 8.35% during the forecast period (2024-2029).

COVID-19 infection became a major public health concern, and clinical nutrition played a crucial role in preventing infection and treating infection-associated malnutrition. Major micronutrients such as vitamins A, B6, B12, folate, C, D, and E and trace elements (Zinc, Selenium, and Copper) are known to play important roles in regulating both innate and adaptive immune responses, which were essential to maintaining during COVID-19. Further, according to the article published by researchers in Europe in December 2022 in the Clinical Nutrition journal, COVID-19 significantly induced severe alterations in the patient's nutritional status, which notably impacted the clinical outcomes. Due to this, the adoption of clinical nutrition products was significantly high during the pandemic, which positively impacted the growth of the studied market over the forecast period. In the current scenario, the market is experiencing its pre-pandemic trends due to the increase in demand for clinical nutrition products as COVID-19-related restrictions have been eased.

The major factors attributing to the growth of the market are the increasing prevalence of metabolic disorders and high spending on healthcare. For instance, according to the 2022 statistics published by the International Diabetes Federation (IDF) Diabetes Atlas, 3.94 million people were diagnosed with diabetes in France in 2021. This number is expected to rise to 4.18 million by 2030 and 4.22 million by 2040 in France. Thus, the increasing burden of diabetes in the region is expected to increase the demand for clinical nutrition, thereby boosting the market growth.

Furthermore, the increasing government initiatives in launching guidelines and aware people regarding clinical nutrition are also contributing to the growth of the market. For instance, in November 2022, German hospitals and nursing homes took part in the new nDay campaign launched by the German Federal Ministry of Food and Agriculture (BMEL) in cooperation with the Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, the German Clinical Nutrition Society (DGEM), and the German Nutrition Society (DGE) to support nationwide participation in the nutritionDay audit (nDay). The campaign provided current data on the prevalence of malnutrition as well as existing care structures in hospitals and nursing homes in Germany. Similarly, in January 2022, World Health Organization/Europe launched a new, voluntary, Member State-led Sugar and Calorie Reduction Network to promote healthier diets as well as reduce overweight and obesity levels across the World Health Organization European Region.

Furthermore, the presence of key market players and their strategic activities, like product launches, agreements, and collaboration to increase product availability in Europe, is further expected to bolster market growth over the forecast period. For instance, in April 2022, Glanbia Nutritionals launched TechVantage at the nutraceutical event Vitafoods Europe. TechVantage will provide customers with nutrient solutions with stability enhancements, the ability to mask flavors/colors, and solubility/flowability improvements. Similarly, in November 2022, Dairy Cooperative Laïta Nutrition launched DADFMS, a powder-based nutritional solution based on dairy proteins, which effectively meets the needs of patients suffering from or at risk of malnutrition (FSMPs). Laïta Nutrition developed this prepacked powder because many pathologies hinder patient autonomy and are associated with swallowing disorders, often leading to the long-term deterioration of nutritional status.

However, imprecise perceptions about clinical nutrition are likely to restrain the market growth over the forecast period.

Europe Clinical Nutrition Industry Segmentation

As per the scope of the report, clinical nutrition is the overall analysis of the relationship between ingested food and the overall well-being of the human body. Clinical nutrition is largely concerned with the prevention, diagnosis, and management of nutritional alterations in individuals who have chronic illnesses and disorders. Clinical nutrition products are useful in maintaining the patient's health and enabling the improvement of the body's metabolic system by providing adequate supplements, such as minerals, vitamins, and other supplements. The European clinical nutrition market is segmented by route of administration (oral, enteral, and parenteral), application (malnutrition, metabolic disorders, gastrointestinal diseases, cancer, neurological diseases, and other diseases), end user (pediatrics and adults), and geography (Germany, the United Kingdom, France, Italy, Spain, and the rest of Europe).

The report offers the value (in USD) for the above segments.

By Route of Administration
Oral and Enteral
Parenteral
By Application
Malnutrition
Metabolic Disorders
Gastrointestinal Diseases
Cancer
Neurological Diseases
Other Diseases
By End User
Pediatric
Adult
Geography
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Need A Different Region Or Segment?
Customize Now

Europe Clinical Nutrition Market Size Summary

The European clinical nutrition market is poised for significant growth, driven by the increasing prevalence of metabolic disorders and a rising geriatric population. The market's expansion is further supported by heightened awareness and government initiatives aimed at promoting clinical nutrition. The COVID-19 pandemic underscored the importance of clinical nutrition in managing infection-related malnutrition, leading to a surge in product adoption. As restrictions ease, the market is returning to pre-pandemic trends, with a continued focus on addressing the nutritional needs of individuals with chronic conditions. The presence of key market players and their strategic activities, such as product launches and collaborations, are expected to bolster market growth over the forecast period.

In the United Kingdom, the market is expected to witness substantial growth due to an increase in malnutrition cases and heightened awareness of clinical nutrition. Strategic initiatives by key players and government bodies are further propelling market expansion. The market is moderately consolidated, with major players like Abbott, Nestle Health Science, Baxter International, B. Braun SE, and Danone S.A. (Nutricia) dominating the landscape. Recent product launches, such as Nutricia's plant-based nutritional supplement, highlight the ongoing innovation within the sector. Overall, the European clinical nutrition market is set to grow, driven by the demand for nutritional therapies to manage chronic diseases and support the health of vulnerable populations.

Explore More

Europe Clinical Nutrition Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Prevalence of Metabolic Disorders

      2. 1.2.2 High Spending on Healthcare and Rise in Geriatric Population

    3. 1.3 Market Restraints

      1. 1.3.1 Imprecise Perception About Clinical Nutrition

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Bargaining Power of Suppliers

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Threat of New Entrants

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD)

    1. 2.1 By Route of Administration

      1. 2.1.1 Oral and Enteral

      2. 2.1.2 Parenteral

    2. 2.2 By Application

      1. 2.2.1 Malnutrition

      2. 2.2.2 Metabolic Disorders

      3. 2.2.3 Gastrointestinal Diseases

      4. 2.2.4 Cancer

      5. 2.2.5 Neurological Diseases

      6. 2.2.6 Other Diseases

    3. 2.3 By End User

      1. 2.3.1 Pediatric

      2. 2.3.2 Adult

    4. 2.4 Geography

      1. 2.4.1 Germany

      2. 2.4.2 United Kingdom

      3. 2.4.3 France

      4. 2.4.4 Italy

      5. 2.4.5 Spain

      6. 2.4.6 Rest of Europe

Europe Clinical Nutrition Market Size FAQs

The Europe Clinical Nutrition Market size is expected to reach USD 21.02 billion in 2024 and grow at a CAGR of 8.35% to reach USD 31.39 billion by 2029.

In 2024, the Europe Clinical Nutrition Market size is expected to reach USD 21.02 billion.

Europe Clinical Nutrition Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)